Romania – Antineoplastic agents – Medicamente Oncologice
In urma incheierii acordului cadru, autoritatea contractanta va incheia contracte subsecvente, in functie de necesitati si fonduri disponibile. Cantitatile minime si maxime care ar putea fi solicitate pe durata intregului acord cadru, precu
Opportunity description
In urma incheierii acordului cadru, autoritatea contractanta va incheia contracte subsecvente, in functie de necesitati si fonduri disponibile. Cantitatile minime si maxime care ar putea fi solicitate pe durata intregului acord cadru, precum si cantitatile minime si maxime care ar putea face obiectul unui singur contract subsecvent sunt specificate in anexa 1 a caietului de sarcini.Valorile estimate a celui mai mare contract subsecvent sunt specificate in caietul de sarcini si sectiunea Loturi, Informatii suplimentare. Cantitatile minime si maxime specificate la fiecare lot, reprezinta cantitatile acordului cadru. Autoritatea contractanta va raspunde in mod clar si complet tuturor solicitarilor de clarificare/informatiilor suplimentare in a 11 - a zi inainte de termenul limita de depunere a ofertelor. Numarul de zile pana la care se pot solicita clarificari, inainte de data limita de depunere a ofertelor este de 20. Aflibercept conc. pt. sol. perf. 25mg/ml - flacon 10 ml x 8 ml concentrat AC. cant. min. 2 - max. 48 Aflibercept conc. pt. sol. perf. 25mg/ml - flacon 5 ml x 4 ml concentrat AC. cant. min. 2 - max. 48 Atezolizumab conc. pt. sol. perf. 1200mg/20ml AC. cant. min. 6 - max. 144 Bevacizumabum conc. pt. sol. perf. 25mg/ml - flacon 16ml AC. cant. min. 10 - max. 240 Bevacizumabum conc. pt. sol. perf. 25mg/ml - flacon 4ml AC. cant. min. 10 - max. 240 bleomycinum sulfas pulb. pt. sol. inj./perf. 15000UI AC. cant. min. 2 - max. 48 Cabazitaxelum conc. pt. sol. perf. 20mg/ml - flacon 3 ml conc. AC. cant. min. 1 - max. 24 Calcii Folinas. sol. inj./perf. 10mg/ml - flacon 10ml AC. cant. min. 12 - max. 288 Carboplatinum conc. pt. sol. perf. 10mg/ml - flacon 45ml AC. cant. min. 10 - max. 240 Carboplatinum conc. pt. sol. perf. 10mg/ml - flacon 15ml AC. cant. min. 10 - max. 240 Cemiplimabum conc. pt. sol. perf. 350mg AC. cant. min. 1 - max. 24 Cetuximabum sol. perf. 5mg/ml flacon 20ml AC. cant. min. 8 - max. 192 Cisplatinum conc. pt. sol. perf. 1mg/ml flacon 50ml AC. cant. min. 10 - max. 240 Cyclophosphamidum conc. pt. sol. perf./ inj. 200mg AC. cant. min. 12 - max. 288 Dacarbazinum pulb. pt. sol. inj./perf. 200mg AC. cant. min. 10 - max. 240 Docetaxelum conc. pt. sol. perf. 80mg/4ml AC. cant. min. 6 - max. 144 Docetaxelum conc. pt. sol. perf. 20mg/1ml AC. cant. min. 4 - max. 96 Doxorubicinum conc. pt. sol. perf. 2mg/ml flacon 25ml AC. cant. min. 6 - max. 144 Doxorubicinum pegylated liposomal conc. pt. dispersie 2mg/ml flacon 10ml AC. cant. min. 2 - max. 48 Durvalumabum conc. pt. sol. perf. 50mg/ml - flacon 10ml AC. cant. min. 2 - max. 48 Epirubicinum sol. inj./perf. 2mg/ml - flacon 25ml AC. cant. min. 10 - max. 240 Epirubicinum sol. inj./perf. 2mg/ml - flacon 50ml AC. cant. min. 8 - max. 192 Fluorouracilum conc. pt. sol. perf. 50mg/ml - flacon 20ml AC. cant. min. 20 - max. 480 Gemcitabinum conc. pt. sol. perf./ inj. 100mg/ml flacon 10ml AC. cant. min. 15 - max. 360 Gemcitabinum conc. pt. sol. perf./ inj. 100mg/ml flacon 2ml AC. cant. min. 10 - max. 240 Ifosfamidum pulb. pt. sol. perf. 1gr/30ml AC. cant. min. 4 - max. 96 Irinotecanum conc. pt. sol. perf. 20mg/ml - flacon 5ml AC. cant. min. 10 - max. 240 Irinotecanum conc. pt. disperie 4.3 mg/ml AC. cant. min. 2 - max. 48 Nivolumabum conc. pt. sol. perf. 10mg/ml - flacon 4 ml AC. cant. min. 10- max. 240 Nivolumabum conc. pt. sol. perf. 10mg/ml - flacon 10 ml AC. cant. min. 20- max. 480 Oxaliplatinum conc. pt. sol. perf. 5mg/ml - flacon 10 ml AC. cant. min. 10 - max. 240 Oxaliplatinum conc. pt. sol. perf. 5mg/ml - flacon 20 ml AC. cant. min. 14 - max. 336 Paclitaxelum conc. pt. sol. perf. 6mg/ml - flacon 16,67 ml AC. cant. min. 10 - max. 240 Paclitaxelum conc. pt. sol. perf. 6mg/ml - flacon 50 ml AC. cant. min. 10 - max. 240 Panitumumabum conc. pt. sol. perf. 20mg/ml - flacon 5 ml AC. cant. min. 1 - max. 24 Pembrolizumabum conc. pt. sol. perf. 25mg/ml - flacon 4 ml AC. cant. min. 28 - max. 672 Pemetrexedum conc. pt. sol. perf. 25mg/ml - flacon 20 ml AC. cant. min. 10 - max. 240 Ramucirumabum conc. pt. sol. perf. 10mg/ml AC. cant. min. 10 - max. 240 Topotecamum conc. pt. sol. perf. 1mg/ml - flacon 2ml AC. cant. min. 8 - max. 192 Trastuzumabum pulb. pt. conc. pt. sol. perf. 420mg AC. cant. min. 1 - max. 24 Trastuzumabum pulb. pt. conc. pt. sol. perf. 150mg AC. cant. min. 1 - max. 24 Trastuzumabum pulb. pt. conc. pt. sol. perf. 60mg AC. cant. min. 1 - max. 24 Trastuzumabum emtansin pulb. pt. conc. pt. sol. perf. 100mg AC. cant. min. 1 - max. 24 Trastuzumabum emtansin pulb. pt. conc. pt. sol. perf. 160mg AC. cant. min. 1 - max. 24 Tremelimumabum conc. pt. sol. perf. 20mg/ml AC. cant. min. 1 - max. 24 Vaccin BCG pulb. + solv. pt. susp. intravezicala AC. cant. min. 10 - max. 240 Transtuzumabum Deruxtecanum pulb. pt. conc. pt. sol. perf. 100mg AC. cant. min. 6 - max. 144 Avelumabum conc. pt. sol. perf. 20mg/ml AC. cant. min. 8 - max. 192 Procedure: open. Estimated value: 24,380,559.36 RON. Review the original TED notice for the complete requirement, lots, amendments and attachments.
Business details are available after sign in
Codes, capabilities, evidence, buyer details and marketplace actions are withheld from the public HTML and API response.